Viewing Study NCT02582632


Ignite Creation Date: 2025-12-24 @ 9:44 PM
Ignite Modification Date: 2026-02-23 @ 9:32 AM
Study NCT ID: NCT02582632
Status: COMPLETED
Last Update Posted: 2021-07-30
First Post: 2015-10-20
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Evaluate Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Treatment-Naïve Hepatitis C Virus Genotype 1b-Infected Adults
Sponsor: AbbVie
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: M15-684
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators